Stocks & Investing
Tue, October 1, 2024
Wed, August 14, 2024
Wed, August 7, 2024
Tue, August 6, 2024
Mon, August 5, 2024
[ Mon, Aug 05th 2024
] - WOPRAI
Fri, July 26, 2024
[ Fri, Jul 26th 2024
] - WOPRAI
Tue, July 9, 2024
[ Tue, Jul 09th 2024
] - WOPRAI
Mon, July 1, 2024
Tue, June 25, 2024
Thu, June 20, 2024
[ Thu, Jun 20th 2024
] - WOPRAI
Tue, June 18, 2024
Fri, May 17, 2024
[ Fri, May 17th 2024
] - WOPRAI
Tue, May 14, 2024
Thu, April 25, 2024
Tue, April 23, 2024
Thu, April 4, 2024
Mon, April 1, 2024
Tue, November 14, 2023
Tue, October 24, 2023
[ Tue, Oct 24th 2023
] - WOPRAI
Mon, October 9, 2023
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
Tue, September 19, 2023
[ Tue, Sep 19th 2023
] - WOPRAI
Mon, September 18, 2023
[ Mon, Sep 18th 2023
] - WOPRAI
Louise Chen Reiterated (zvra) at Buy on, Oct 1st, 2024
Louise Chen of Cantor Fitzgerald, Reiterated "Zevra Therapeutics, Inc." (ZVRA) at Buy on, Oct 1st, 2024.
Louise has made no other calls on ZVRA in the last 4 months.
There are 5 other peers that have a rating on ZVRA. Out of the 5 peers that are also analyzing ZVRA, 0 agree with Louise's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Louise
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $20 on, Monday, September 30th, 2024
- Jason Butler of "JMP Securities" Initiated at Buy and Held Target at $17 on, Tuesday, September 24th, 2024
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $25 on, Tuesday, September 24th, 2024
- Jonathan Aschoff of "Roth MKM" Maintained at Strong Buy with Increased Target to $21 on, Tuesday, September 24th, 2024
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $22 on, Wednesday, September 18th, 2024
